首页 | 本学科首页   官方微博 | 高级检索  
检索        


Reply to: “Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?”
Authors:Shira Zelber-Sagi  Yochai Schonmann  Hanny Yeshua  Itay Bentov
Institution:1. School of Public Health, University of Haifa, 3498838 Haifa, Israel;2. Liver Unit, Department of Gastroenterology, Tel-Aviv Medical Center, 6423906 Tel-Aviv, Israel;3. Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel;4. Department of Quality Measurements and Research, Clalit Health Services, Tel Aviv, Israel;5. Clalit Health Services, Tel-Aviv District, Israel;6. Department of Family Medicine, Rabin Medical Center, Petah Tikva, Israel;7. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel;8. Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号